PT Diagnos Laboratorium Utama Tbk (DGNS) Stock Price & Analysis
DGNS Stock Chart & Stats
- Day’s Range
- IDR 286.00 - IDR 302.00
- 52-Week Range
- IDR 140.00 - IDR 382.00
- Previous Close
- IDR 292.00
- Volume
- N/A
- Average Volume (3M)
- 2.42M
- Market Cap
- IDR 398.75B
- Enterprise Value
- IDR 469.87B
- Total Cash (Recent Filing)
- IDR 18.20B
- Total Debt (Recent Filing)
- IDR 73.06B
- Price to Earnings (P/E)
- 155.9
- Beta
- 0.77
- Next Earnings
- Apr 06, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Aug 06, 2021
- Dividend Yield
- N/A
DGNS FAQ
What was PT Diagnos Laboratorium Utama Tbk’s price range in the past 12 months?
What is PT Diagnos Laboratorium Utama Tbk’s market cap?
When is PT Diagnos Laboratorium Utama Tbk’s upcoming earnings report date?
How were PT Diagnos Laboratorium Utama Tbk’s earnings last quarter?
Is PT Diagnos Laboratorium Utama Tbk overvalued?
Does PT Diagnos Laboratorium Utama Tbk pay dividends?
What is PT Diagnos Laboratorium Utama Tbk’s EPS estimate?
How many shares outstanding does PT Diagnos Laboratorium Utama Tbk have?
What happened to PT Diagnos Laboratorium Utama Tbk’s price movement after its last earnings report?
Which hedge fund is a major shareholder of PT Diagnos Laboratorium Utama Tbk?
What is the TipRanks Smart Score and how is it calculated?
Company Description
PT Diagnos Laboratorium Utama Tbk
PT Diagnos Laboratorium Utama Tbk delivers comprehensive medical laboratory services across Indonesia. The company offers a wide range of diagnostic tests, including clinical pathology services covering hematology, hemostasis, clinical chemistry, urinalysis, biomolecular analysis, immunology, and microbiology. It also performs anatomical pathology for the detailed examination of tissues and body fluids. Furthermore, PT Diagnos specializes in advanced genomics testing, such as non-invasive prenatal screening (NIPT) and preimplantation genetic testing for both aneuploidy and monogenic diseases. Beyond its core laboratory offerings, the company provides convenient home-based health check-ups, tailored corporate wellness programs, and specialized COVID-19 testing. Its broader involvement extends to supporting various healthcare initiatives and infrastructure, including maintaining specialized biological banks (e.g., eye, blood, sperm, and organ banks) and pharmacy warehousing, in collaboration with both public and private sector entities. Established in 2007, the company's headquarters are located in Jakarta Pusat, Indonesia.
- Sector
- General
- Industry
- Medical - Diagnostics & Research
- CEO
- Fergus Richard
- Employees
- 81
- Website
- diagnos.co.id
- Address
- Gedung Graha Anam Lantai 2, Jakarta Pusat, JK, 1500358, ID
PT Diagnos Laboratorium Utama Tbk (DGNS) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 6 | 0 |
| Technical Analysis | 4 | 6 | 0 |
| Moving Averages | 12 | 0 | 0 |

